Search
Now showing items 11-20 of 59
Papers presented at events
Expression, purification and characterization of S542-931 and RBD330-524 from spike protein of SARS-Cov-2
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Inactivated SARS-CoV-2 for safe use in analytical and non-clinical trials
| Date Issued:
2022 | Copyright:
open access
Papers presented at events
Development of anti-SARS-CoV-2 specific scFv antibody library from convalescent plasma of COVID-19 recovered patients using phage display technology
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Development of a rapid test for detection of anti-COVID-19 IgG and IgM antibodies
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Expression, purification and characterization of the SARS-CoV-2 nucleocapsid antigen
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Assessment of humoral response to SARS-CoV-2 using an ELISA kit, developed and validated at references laboratories in Brazil
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Assessment antiviral activity of functional textiles: pioneering service offered by Bio- Manguinhos to partners
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Development of monoclonal antibodies targeting SARS-CoV-2 Spike and Nucleocapsid proteins
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Standardization of a plaque reduction test and evaluation of neutralizing antibodies responses to SARS-CoV-2
| Date Issued:
2021 | Copyright:
open access